This episode features Dr Michael Racke discussing the evolution of treating neurologic disease to detect disease early and focus on prevention. In this session, Dr Racke discusses:
- How diagnostics and treatment has evolved for multiple sclerosis
- Treating patients at the first incidence of neurologic disease for optimal outcomes
- How health systems can address the needs of patients with complex neurologic conditions to minimize the human and economic toll of disease
Michael Racke MD Bio:
Dr Michael K. Racke is Medical Director for Neurology at Quest Diagnostics. Dr Racke is a leader in the field of neurology and neuroimmunology. Dr Racke is the author of more than 200 peer-reviewed papers, book chapters, and reviews spanning the pathogenesis of neuroimmunologic diseases. He continues to serve on several national professional society committees.
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest Diagnostics annually serves 1 in 3 adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
More information is available at www.QuestDiagnostics.com